https://www.who.int/news-room/detai...-globally-due-to-gaps-in-vaccination-coverage
Measles cases spike globally due to gaps in vaccination coverage
29 November 2018
News Release
Geneva/Atlanta/New York
AddThis Sharing Buttons
Share to Print
Share to EmailShare to FacebookShare to TwitterShare to More
Reported measles cases spiked in 2017, as multiple countries experienced severe and protracted outbreaks of the disease. This is according to a new report published today by leading health organizations.
Because of gaps in vaccination coverage, measles outbreaks occurred in all regions, while there were an estimated 110 000 deaths related to the disease.
Using updated disease modelling data, the report provides the most comprehensive estimates of measles trends over the last 17 years. It shows that since 2000, over 21 million lives have been saved through measles immunizations. However, reported cases increased by more than 30 percent worldwide from 2016.
The Americas, the Eastern Mediterranean Region, and Europe experienced the greatest upsurges in cases in 2017, with the Western Pacific the only World Health Organization (WHO) region where measles incidence fell.
“The resurgence of measles is of serious concern, with extended outbreaks occurring across regions, and particularly in countries that had achieved, or were close to achieving measles elimination,” said Dr Soumya Swaminathan, Deputy Director General for Programmes at WHO. “Without urgent efforts to increase vaccination coverage and identify populations with unacceptable levels of under-, or unimmunized children, we risk losing decades of progress in protecting children and communities against this devastating, but entirely preventable disease.”
Measles is a serious and highly contagious disease. It can cause debilitating or fatal complications, including encephalitis (an infection that leads to swelling of the brain), severe diarrhoea and dehydration, pneumonia, ear infections and permanent vision loss. Babies and young children with malnutrition and weak immune systems are particularly vulnerable to complications and death.
The disease is preventable through two doses of a safe and effective vaccine. For several years, however, global coverage with the first dose of measles vaccine has stalled at 85 percent. This is far short of the 95 percent needed to prevent outbreaks, and leaves many people, in many communities, susceptible to the disease. Second dose coverage stands at 67 percent.
“The increase in measles cases is deeply concerning, but not surprising,” said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance. “Complacency about the disease and the spread of falsehoods about the vaccine in Europe, a collapsing health system in Venezuela and pockets of fragility and low immunization coverage in Africa are combining to bring about a global resurgence of measles after years of progress. Existing strategies need to change: more effort needs to go into increasing routine immunization coverage and strengthening health systems. Otherwise we will continue chasing one outbreak after another.”
Responding to the recent outbreaks, health agencies are calling for sustained investment in immunization systems, alongside efforts to strengthen routine vaccination services. These efforts must focus especially on reaching the poorest, most marginalized communities, including people affected by conflict and displacement.
The agencies also call for actions to build broad-based public support for immunizations, while tackling misinformation and hesitancy around vaccines where these exist.
“Sustained investments are needed to strengthen immunization service delivery and to use every opportunity for delivering vaccines to those who need them,” said Dr Robert Linkins, Branch Chief of Accelerated Disease Control and Vaccine Preventable Disease Surveillance at the U.S. Centers for Disease Control and Prevention (CDC) and Measles & Rubella Initiative Management Team Chair.
The Measles and Rubella Initiative is a partnership formed in 2001 of the American Red Cross, CDC, the United Nations Foundation, UNICEF, and WHO.
Note to editors
‘Progress Toward Regional Measles Elimination — Worldwide, 2000–2017’ is a joint publication of WHO and CDC. It is published within the WHO Weekly Epidemiological Record and in CDC’s Morbidity and Mortality Weekly Report.
Launched in 2001, the Measles & Rubella Initiative (M&RI) is led by the American Red Cross, the United Nations Foundation, CDC, UNICEF and WHO. M&RI is committed to ensuring that no child dies from measles or is born with congenital rubella syndrome, and achieving the Global Vaccine Action Plan goal of measles and rubella elimination in at least five WHO regions by 2020.
Measles elimination is defined as the absence of endemic measles virus transmission in a region or other defined geographical area for more than 12 months. Conversely, a country is no longer considered to be measles free if the virus returns and transmission is sustained continuously for more than a year.
Further information
The report is available in CDC’s Morbidity and Mortality Weekly Report as of November 29 2018 and in WHO’s Weekly Epidemiological Record from November 30 2018.
Further information on immunization progress is also contained within the 2018 Assessment Report of The Global Vaccine Action Plan by the Strategic Advisory Group of Experts on Immunization, published in November 2018.
Subscribe to the WHO newsletter →
Media Contacts
Christian Lindmeier
Communications Officer
WHO
Telephone: 0041227911948
Mobile: 0041795006552
Email: [email protected]
Amy Rowland
Centers for Disease Control and Prevention
Telephone: +1 770 488 5104
Mobile: +1 678-332-9601
Email: [email protected]
James Fulker
GAVI
Telephone: 0041229092926
Mobile: 0041794295505
Email: [email protected]
Sabrina Sidhu
UNICEF
Telephone: +12128246583
Mobile: +1 917 476 1537
Email: [email protected]
News
Substantial decline in global measles deaths, but disease still kills 90 000 per year 26 October 2017
Fact sheets
Measles 29 November 2018
Feature stories
Millions of children to receive measles vaccine in north-eastern Nigeria 16 January 2017
https://www.who.int/immunization/mo...veillance_type/active/measles_monthlydata/en/
Immunization, Vaccines and Biologicals
Measles and Rubella Surveillance Data
Description:
Timely measles and rubella surveillance is critical to disease control. Identifying and confirming suspected measles and rubella cases through surveillance allows:
1) early detection of outbreaks,
2) analysis of on-going transmission in order to mount more effective vaccination measures, and
3) estimation of the underlying true incidence based on the patterns in reported data.
Most Member States submit monthly reports on suspected and confirmed measles and rubella cases identified through their national disease surveillance systems to WHO. In general, the number of reported cases reflects a small proportion of the true number of cases occurring in the community. Many cases do not seek health care or, if diagnosed, are not reported. In addition, there is a one to two month lag time in reporting. For these reasons, the data provided on this page under-represents the true number of cases, particularly those occurring in the last one to two months.
Please note that all data contained within is provisional. The annual number of cases of measles and rubella officially reported by a member state is only available by July of each following year (through the joint WHO UNICEF annual data collection exercise). If any numbers from this provisional data are quoted, they should be properly sourced with a date (i.e. “provisional data based on monthly data reported to WHO (Geneva) as of March 2019”). For official data from 1980-2017, please visit our website.
Measles and Rubella Surveillance Data
Distribution of measles genotypes in 2010
Distribution of measles genotypes in 2011
Distribution of measles genotypes in 2012
Distribution of measles genotypes in 2013
Distribution of measles genotypes in 2014
Distribution of measles genotypes in 2015
Related links
Measles cases spike globally due to gaps in vaccination coverage
29 November 2018
News Release
Geneva/Atlanta/New York
AddThis Sharing Buttons
Share to Print
Share to EmailShare to FacebookShare to TwitterShare to More
Reported measles cases spiked in 2017, as multiple countries experienced severe and protracted outbreaks of the disease. This is according to a new report published today by leading health organizations.
Because of gaps in vaccination coverage, measles outbreaks occurred in all regions, while there were an estimated 110 000 deaths related to the disease.
Using updated disease modelling data, the report provides the most comprehensive estimates of measles trends over the last 17 years. It shows that since 2000, over 21 million lives have been saved through measles immunizations. However, reported cases increased by more than 30 percent worldwide from 2016.
The Americas, the Eastern Mediterranean Region, and Europe experienced the greatest upsurges in cases in 2017, with the Western Pacific the only World Health Organization (WHO) region where measles incidence fell.
“The resurgence of measles is of serious concern, with extended outbreaks occurring across regions, and particularly in countries that had achieved, or were close to achieving measles elimination,” said Dr Soumya Swaminathan, Deputy Director General for Programmes at WHO. “Without urgent efforts to increase vaccination coverage and identify populations with unacceptable levels of under-, or unimmunized children, we risk losing decades of progress in protecting children and communities against this devastating, but entirely preventable disease.”
Measles is a serious and highly contagious disease. It can cause debilitating or fatal complications, including encephalitis (an infection that leads to swelling of the brain), severe diarrhoea and dehydration, pneumonia, ear infections and permanent vision loss. Babies and young children with malnutrition and weak immune systems are particularly vulnerable to complications and death.
The disease is preventable through two doses of a safe and effective vaccine. For several years, however, global coverage with the first dose of measles vaccine has stalled at 85 percent. This is far short of the 95 percent needed to prevent outbreaks, and leaves many people, in many communities, susceptible to the disease. Second dose coverage stands at 67 percent.
“The increase in measles cases is deeply concerning, but not surprising,” said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance. “Complacency about the disease and the spread of falsehoods about the vaccine in Europe, a collapsing health system in Venezuela and pockets of fragility and low immunization coverage in Africa are combining to bring about a global resurgence of measles after years of progress. Existing strategies need to change: more effort needs to go into increasing routine immunization coverage and strengthening health systems. Otherwise we will continue chasing one outbreak after another.”
Responding to the recent outbreaks, health agencies are calling for sustained investment in immunization systems, alongside efforts to strengthen routine vaccination services. These efforts must focus especially on reaching the poorest, most marginalized communities, including people affected by conflict and displacement.
The agencies also call for actions to build broad-based public support for immunizations, while tackling misinformation and hesitancy around vaccines where these exist.
“Sustained investments are needed to strengthen immunization service delivery and to use every opportunity for delivering vaccines to those who need them,” said Dr Robert Linkins, Branch Chief of Accelerated Disease Control and Vaccine Preventable Disease Surveillance at the U.S. Centers for Disease Control and Prevention (CDC) and Measles & Rubella Initiative Management Team Chair.
The Measles and Rubella Initiative is a partnership formed in 2001 of the American Red Cross, CDC, the United Nations Foundation, UNICEF, and WHO.
Note to editors
‘Progress Toward Regional Measles Elimination — Worldwide, 2000–2017’ is a joint publication of WHO and CDC. It is published within the WHO Weekly Epidemiological Record and in CDC’s Morbidity and Mortality Weekly Report.
Launched in 2001, the Measles & Rubella Initiative (M&RI) is led by the American Red Cross, the United Nations Foundation, CDC, UNICEF and WHO. M&RI is committed to ensuring that no child dies from measles or is born with congenital rubella syndrome, and achieving the Global Vaccine Action Plan goal of measles and rubella elimination in at least five WHO regions by 2020.
Measles elimination is defined as the absence of endemic measles virus transmission in a region or other defined geographical area for more than 12 months. Conversely, a country is no longer considered to be measles free if the virus returns and transmission is sustained continuously for more than a year.
Further information
The report is available in CDC’s Morbidity and Mortality Weekly Report as of November 29 2018 and in WHO’s Weekly Epidemiological Record from November 30 2018.
Further information on immunization progress is also contained within the 2018 Assessment Report of The Global Vaccine Action Plan by the Strategic Advisory Group of Experts on Immunization, published in November 2018.
Subscribe to the WHO newsletter →
Media Contacts
Christian Lindmeier
Communications Officer
WHO
Telephone: 0041227911948
Mobile: 0041795006552
Email: [email protected]
Amy Rowland
Centers for Disease Control and Prevention
Telephone: +1 770 488 5104
Mobile: +1 678-332-9601
Email: [email protected]
James Fulker
GAVI
Telephone: 0041229092926
Mobile: 0041794295505
Email: [email protected]
Sabrina Sidhu
UNICEF
Telephone: +12128246583
Mobile: +1 917 476 1537
Email: [email protected]
News
Substantial decline in global measles deaths, but disease still kills 90 000 per year 26 October 2017
Fact sheets
Measles 29 November 2018
Feature stories
Millions of children to receive measles vaccine in north-eastern Nigeria 16 January 2017
https://www.who.int/immunization/mo...veillance_type/active/measles_monthlydata/en/
Immunization, Vaccines and Biologicals
- Immunization, Vaccines and Biologicals
- Vaccines and diseases
- Global Vaccine Action Plan
- WHO policy recommendations
- National programmes and systems
- Monitoring and surveillance
- Quality, safety and standards
- Research and development
- Resource materials
- Newsroom
Measles and Rubella Surveillance Data
Description:
Timely measles and rubella surveillance is critical to disease control. Identifying and confirming suspected measles and rubella cases through surveillance allows:
1) early detection of outbreaks,
2) analysis of on-going transmission in order to mount more effective vaccination measures, and
3) estimation of the underlying true incidence based on the patterns in reported data.
Most Member States submit monthly reports on suspected and confirmed measles and rubella cases identified through their national disease surveillance systems to WHO. In general, the number of reported cases reflects a small proportion of the true number of cases occurring in the community. Many cases do not seek health care or, if diagnosed, are not reported. In addition, there is a one to two month lag time in reporting. For these reasons, the data provided on this page under-represents the true number of cases, particularly those occurring in the last one to two months.
- Reported measles and rubella cases and incidence rates by Member States
xlsx, 35kb - Distribution of measles cases by country and by month, 2011-2019
xlsx, 117kb - Distribution of rubella cases by country and by month, 2015-2019
xlsx, 64kb
Please note that all data contained within is provisional. The annual number of cases of measles and rubella officially reported by a member state is only available by July of each following year (through the joint WHO UNICEF annual data collection exercise). If any numbers from this provisional data are quoted, they should be properly sourced with a date (i.e. “provisional data based on monthly data reported to WHO (Geneva) as of March 2019”). For official data from 1980-2017, please visit our website.
- Immunization, Vaccines and Biologicals
- Vaccines and diseases
- Global Vaccine Action Plan
- WHO policy recommendations
- National programmes and systems
- Monitoring and surveillance
- Quality, safety and standards
- Research and development
- Resource materials
- Newsroom
Measles and Rubella Surveillance Data
Distribution of measles genotypes in 2010
Distribution of measles genotypes in 2011
Distribution of measles genotypes in 2012
Distribution of measles genotypes in 2013
Distribution of measles genotypes in 2014
Distribution of measles genotypes in 2015
Related links
